Whalesbook
Strong Q3 FY'26 for KMC Speciality Hospitals with 83% PAT Growth
KMC Speciality Hospitals (Kauvery Hospital) announced strong financial results for the third quarter of fiscal year 2026 (Q3 FY'26), ending December 31, 2025. Profit After Tax (PAT) surged 83% year-on-year to ₹13.7 Cr, compared to ₹7.5 Cr in the prior year's quarter.
Total income rose by an impressive 33% year-on-year to ₹83.2 Cr, up from ₹62.6 Cr in Q3 FY'25. This revenue growth was coupled with a substantial 50% increase in EBITDA to ₹25.9 Cr, boosting EBITDA margins to a healthy 31.1%. PAT margins reached 16.5%.
Operational metrics demonstrated strong performance, with Occupied Bed Days increasing by 11% year-on-year. In-Patient Volumes grew by 18%, and Out-Patient Volumes saw a significant 32% rise. The company also highlighted the continued strong performance of its Mother and Child Care services, which contributed 27% to total income.
These results reflect strong operational performance and higher demand for the hospital's specialized healthcare services. This suggests improved pricing, cost control, or a shift in the service mix, all contributing to higher profits.
Expansion Fuels Growth
Kauvery Hospital, a prominent healthcare provider in South India, is pursuing an aggressive expansion strategy. As of late 2025, the group planned to add approximately 1,000 beds between FY25 and FY27, supported by ₹580 crore in capital expenditure. This plan aims to scale its network across South India, with KMC Speciality Hospitals (India) Ltd. operating as a key subsidiary. In February 2026, KMC Speciality Hospitals provided a corporate guarantee of ₹98.57 crore for its holding company's loan.
Competitive Landscape and Risks
While larger peers like Apollo Hospitals and Max Healthcare have larger market capitalizations, KMC Speciality Hospitals' Q3 FY'26 performance shows strong percentage growth in PAT and revenue, indicating significant operational progress and efficiency gains in its sector.
However, the company remains susceptible to widespread inflation that could impact operating costs, despite its domestic performance.